The stock of Citius Pharmaceuticals Inc (NASDAQ: CTXR) was maintained at $3.23.This company is pleased to usher in a leading scholar in Acute Respiratory Distress Syndrome (ARDS) to its scientific advisory board. The new official is called Dr. John Laffey, and he is expected to be of great value in helping the company […]